PWMG
AMPH icon

Prestige Wealth Management Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Prestige Wealth Management Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-24
Closed – – 519
2018
Q4 		$0 Buy
+24
New +$473 ﹤0.01% 1237

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prestige Wealth Management Group's AMPH Position: Q1 2019 in Review

Prestige Wealth Management Group sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2019, closing a stake of 24 shares.

Prestige Wealth Management Group first reported a position in AMPH in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 135 funds tracked by Wall St. Rank hold AMPH as of Q1 2019.

  • Prestige Wealth Management Group reported no remaining Amphastar Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Prestige Wealth Management Group sold 24 Amphastar Pharmaceuticals shares in Q1 2019.
  • Prestige Wealth Management Group first reported a position in Amphastar Pharmaceuticals in Q4 2018 and held it in 1 quarter.
  • Prestige Wealth Management Group's Amphastar Pharmaceuticals position peaked at $0 in Q4 2018.
  • 135 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2019.

Based on Prestige Wealth Management Group's 13F filing for Q1 2019, filed 16 Aug 2019.